GAC - We may get your theory on the effect of RBC or BMO's involvement at some point. There are many houses that wouldn't pay any attention at all to this little Cdn biotech in the past because no one in that business likes to go first. As we gain momentum more and more people will be asking about it (their clients included). Not wanting to now miss the boat so to speak they may end up having to write a piece even though at that time they may not get paid for it. If the drug is as good as what we all hope it is then many more houses will jump on the band wagon and head to the party.

Here's hoping!

tada